We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
38 hedge funds and large institutions have $85.1M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
343% more call options, than puts
Call options by funds: $541K | Put options by funds: $122K
113% more capital invested
Capital invested by funds: $40M → $85.1M (+$45.1M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
12% less funds holding
Funds holding: 43 → 38 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
10
Reduced
8
Closed
10
Calls
$541K
Puts
$122K
Net Calls
+$419K
Net Calls Change
+$385K
Top Buyers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$4.72M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$984K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$877K |
| 4 |
Two Sigma Investments
New York
|
+$176K |
| 5 |
Two Sigma Advisers
New York
|
+$166K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$383K |
| 2 |
Millennium Management
New York
|
-$71K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$35K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$26.8K |
| 5 |
HF
HRT Financial
New York
|
-$22K |
